ProGRP and Neuron-specific enolase (NSE) are well-recognized biomarkers of SCLC diagnosis; however, they are found to have low sensitivity and specificity [24,25,26,27,28,29,30,31,32]. This evidence concerns the gene ENO2 and small cell lung carcinoma.